Website intended for a NZ health professional readership
Sexual health specialist Massimo Giola looks at the evidence for doxycycline post-exposure prophylaxis as a prevention tool for bacterial sexually transmitted infections
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
1. Highleyman L. Sexually transmitted infections in San Francisco have fallen since doxyPEP roll-out. 5 March 2024.
2. Bachmann LH, Barbee LA, Chan P, et al. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recomm Rep 2024;73(2):1–8.
3. Cornelisse VJ, Riley B, Medland NA. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men. Med J Aust 2024;220(7):381–86.
Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
Ever heard these myths from smokers?
